Close

Canaccord Genuity Suggests Buying NPS Pharmaceuticals (NPSP) on Weakness Following GATTEX Cancer Signal Nov 1, 2011 08:27AM
Canaccord Genuity reiterates a 'Buy' on NPS Pharmaceuticals (NPSP); Encouraging Data Points Picked Up During Management/Investor Meeting Oct 17, 2011 08:39AM
Canaccord Genuity Reiterates a 'Buy' on NPS Pharmaceuticals (NPSP); New Data Supports 558 Promise Sep 19, 2011 09:06AM
Canaccord Genuity Reiterates a 'Buy' on NPS Pharmaceuticals (NPSP); Gattex Trial Updates Support Big Potential May 12, 2011 11:07AM
Canaccord Genuity Maintains a 'Buy' on NPS Pharmaceuticals (NPSP); GATTEX Phase III Data at DDW May 5, 2011 12:09PM


Apr 7, 2011 10:51AM Canaccord Genuity Reiterates a 'Buy' on NPS Pharmaceuticals (NPSP); SBS Expert Call Highlights
Feb 15, 2011 11:20AM Canaccord Genuity Maintains a 'Buy' on NPS Pharmaceuticals (NPSP); Underappreciated Potential of GATTEX
Jan 31, 2011 02:45PM Notable 52-Week Highs and Lows of the Day 01/31: XOM, DEPO, NPSP, PLL High; BGP, AIB Low
Jan 31, 2011 09:36AM Canaccord Genuity Maintains a 'Buy' on NPS Pharmaceuticals (NPSP) GATTEX Achieves Major Goal in STEPS
Jan 19, 2011 12:02PM Canaccord Genuity Maintains a 'Buy' on NPS Pharmaceuticals (NPSP); Anticipating GATTEX Phase III Success
Dec 14, 2010 09:13AM Canaccord Genuity on Life Sciences/Biotechnology: BEST IDEAS FOR 2011: AMRN, DNDN, FOLD, NPSP, OREX, VRUS
Nov 3, 2010 12:43PM Canaccord Genuity Reiterates a 'Buy' on NPS Pharmaceuticals (NPSP); Maintaining Positive View on P3 Outcomes
Sep 15, 2010 04:03PM NPS Pharma (NPSP) Announces $41.29M Common Offering